Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT ID: NCT05764005
Last Updated: 2024-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-11-09
2024-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
NCT01900561
The Active Surveillance Study
NCT05810467
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
NCT02957357
Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer
NCT05940415
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
NCT05840484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention website
web-based tool (MAP- Management of Active surveillance in Prostate Cancer)
A web-based tool with modules on active surveillance education, team based active surveillance care delivery and the role of the PCP, and self-management for cancer anxiety and worry. {may need more detail}
Control MUSIC website
This is usual care and all urologists are encouraged to refer their patients to the patient educational materials on the MUSIC website (http://www.musicurology.com/patientmaterials/).
MUSIC website
Standard of care educational materials {add more detail}
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
web-based tool (MAP- Management of Active surveillance in Prostate Cancer)
A web-based tool with modules on active surveillance education, team based active surveillance care delivery and the role of the PCP, and self-management for cancer anxiety and worry. {may need more detail}
MUSIC website
Standard of care educational materials {add more detail}
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men diagnosed with low-risk prostate cancer currently on active surveillance
* Men who identify having a primary care provider
* Access and ability to use the Internet
* Identified by patient on baseline survey as their PCP
* Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses
Exclusion Criteria
* Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss)
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Michigan Rogel Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Archana Radhakrishnan
Role: PRINCIPAL_INVESTIGATOR
University of Michigan Rogel Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00209599
Identifier Type: OTHER
Identifier Source: secondary_id
UMCC 2022.059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.